Article Per Year (5 Year)
p-Index From 2020 - 2025
1.857
P-Index
This Author published in this journals
All Journal Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) Jurnal Biomedika dan Kesehatan Indonesian Journal of Pharmaceutical and Clinical Research Lamahu: Jurnal Pengabdian Masyarakat Terintegrasi Sainsbertek Jurnal Ilmiah Sains & Teknologi JCSE: Journal of Community Service and Empowerment Jurnal Farmasi Ma Chung: Sains, Teknologi, dan Klinis Komunitas Khidmat: Journal Community Service
Nugraha, Dhanang Prawira
Unknown Affiliation
Arts Humanities Biochemistry, Genetics & Molecular Biology Chemistry Computer Science & IT Decision Sciences, Operations Research & Management Earth & Planetary Sciences Economics, Econometrics & Finance Education Engineering Environmental Science Health Professions Immunology & microbiology Industrial & Manufacturing Engineering Languange, Linguistic, Communication & Media Law, Crime, Criminology & Criminal Justice Medicine & Pharmacology Public Health Social Sciences Other

Published : 11 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search
Journal : Jurnal Farmasi Galenika (Galenika Journal of Pharmacy)

 1 
Evaluation of Anti-diabetic Drugs using ATC/DDD and DU90% Methods in Diabetes Mellitus Patients: Evaluasi Obat Antidiabetik menggunakan Metode ATC/DDD dan DU90% pada Pasien Diabetes Melitus Hendra, Godeliva Adriani; Nugraha, Dhanang Prawira; Krisdia, Tuswatul Anggi
Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) (e-Journal) Vol. 10 No. 1 (2024): (March 2024)
Publisher : Universitas Tadulako

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22487/j24428744.2024.v10.i1.16624

Abstract

Background: Diabetes Mellitus (DM), which results from insulin resistance, is closely linked to long-term damage to pancreatic beta cells, organ dysfunction, and organ failure, particularly in the eyes, kidneys, nerves, heart, and blood vessels. The development of the ATC/DDD system is necessary to increase global drug knowledge, ensure equitable drug availability, and promote responsible drug use. Objectives: This study aimed to identify data on patient characteristics and oral anti-diabetic drugs and insulin using the ATC/DDD and DU90% methods. Material and Methods: This study was a cross-sectional evaluation of oral anti-diabetic medications and insulin using the ATC/DDD method and DU90% at the Bala Keselamatan Bokor Turen Hospital from January to December 2022. The inclusion criteria were patients diagnosed with type 1 or type 2 diabetes mellitus, with or without comorbidities, who were treated with oral anti-diabetic medications and a combination of insulin and oral medications. In the present study, the incomplete medical record data served as the exclusion criteria. The sample for this investigation consisted of 238 patients selected using the complete sampling technique. Results: Most patients who used oral anti-diabetic medications and insulin were between the ages of 46 and 65 (71.34%), were female (73.2%), had standard body mass index (BMIs between 18.5 and 25), and had diagnoses of DM + HT (20.73%) and Type II DM (18.29%). Glulisin was the most used anti-diabetic drug, accounting for 589 DDD/100 days of hospitalization, and DU90% was 21.39%. Conclusion: Glulisin is the most frequently prescribed anti-diabetic medication at Bokor Turen Hospital.
Co-Authors Ana Amalia, Ana Aziz, Nur Bila, Naura Syifa Salsa Ernawati, Eli Eva Monica, Eva Godeliva Adriani Hendra Kirana, Alda Galuh Krisdia, Tuswatul Anggi Martanty Aditya, Martanty Molly, Pucthree Nawawi, Achmad Zulkifli Oktafiona, Eki Wulan Oktaviana M, Ikfa Rizki Alifa, Almana Rodiyah, Enik Rollando, Rollando shida, Fika sham Susanto, F.X Haryanto Susanto, FX Haryanto